Endocrine Abstracts

Early-onset type 2 diabetes (EOT2D) is the diagnosis of type 2 diabetes in people under the age of forty. This audit assessed the characteristics and management of patients with EOT2D, attending Sligo University Hospital (SUH). This serves to highlight improvement areas in our current practice and aids the development of an optimal care model for this high-risk cohort. All individuals meeting the diagnostic criteria for EOT2D were included. The data was collected from ProWellness, the IT system used for diabetes at SUH and Sligo Chronic Disease Management Hub. The data collected includes age, BMI, current HbA1c, HbA1c at diagnosis, blood pressure, LDL and total cholesterol, diabetes treatment and referral to DESMOND or My Best Health programme. EOT2D was identified in 107 patients. The mean age was 35.3 years. The mean HbA1c at diagnosis was 73 mmol/l/mol. Currently, 47% had a HbA1c below 53 mmol/l/mol. The mean BMI was 30 kg/m², while the mean total cholesterol and LDL were 4.7 mmol/l/land 2.9 mmol/l/lrespectively. 20% of the cohort had been referred to DESMOND or My Best Health Programme. The most common treatment agents were metformin (83%), insulin (28%), GLP-1 agonist (27%) and SGLT-2 inhibitors (24%). There is a significant patient cohort attending SUH with EOT2D, sub-optimal glycaemic and cardio-metabolic risk profiles, with few of them on GLP 1 agonists or SGLT2 inhibitors. A dedicated EOT2D clinic has commenced at SUH, to provide the focus, environment and multidisciplinary team input needed to administer effective, intense and quality care to this high-risk group.